Psychometric properties of the sit-to-stand test for patients with pulmonary hypertension: A systematic review protocol.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 30 11 2021
accepted: 10 09 2022
entrez: 5 10 2022
pubmed: 6 10 2022
medline: 12 10 2022
Statut: epublish

Résumé

Pulmonary hypertension (PH) is a complex syndrome characterized by increased pulmonary arterial pressure and classified into five groups, according to dyspnea on exertion and systemic muscle dysfunction. These symptoms can be identified using the sit-to-stand test (STS), which indirectly evaluates exercise tolerance and lower limb muscle strength. Previous studies used the STS in PH; however, psychometric properties to understand and validate this test were not described for patients with PH. To evaluate the psychometric properties (validity, reliability, and responsiveness) of different STS protocols in patients with PH. This is a systematic review protocol that will include studies using STS in patients with PH. Searches will be conducted on PubMed/MEDLINE, EMBASE, SciELO, Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science databases following PICOT mnemonic strategy and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P). Rayyan software will be used for study selection. The Risk of bias will be assessed using the Consensus-Based Standards for the Selection of Health Measurement Instruments (COSMIN) tool, while the quality of evidence will be assessed using the modified Grading of Recommendations, Assessment, Development, and Evaluation (GRADE). Two researchers will independently conduct the study, and a third researcher will be consulted in case of disagreement. The psychometric properties will be evaluated according to the COSMIN. This protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO, no. CRD42021244271). This systematic review will attempt to identify and show the available evidence on STS for different groups of PH and report validity, reliability, and responsiveness of different protocols.

Sections du résumé

BACKGROUND
Pulmonary hypertension (PH) is a complex syndrome characterized by increased pulmonary arterial pressure and classified into five groups, according to dyspnea on exertion and systemic muscle dysfunction. These symptoms can be identified using the sit-to-stand test (STS), which indirectly evaluates exercise tolerance and lower limb muscle strength. Previous studies used the STS in PH; however, psychometric properties to understand and validate this test were not described for patients with PH.
OBJECTIVE
To evaluate the psychometric properties (validity, reliability, and responsiveness) of different STS protocols in patients with PH.
METHODS AND ANALYSES
This is a systematic review protocol that will include studies using STS in patients with PH. Searches will be conducted on PubMed/MEDLINE, EMBASE, SciELO, Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science databases following PICOT mnemonic strategy and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P). Rayyan software will be used for study selection. The Risk of bias will be assessed using the Consensus-Based Standards for the Selection of Health Measurement Instruments (COSMIN) tool, while the quality of evidence will be assessed using the modified Grading of Recommendations, Assessment, Development, and Evaluation (GRADE). Two researchers will independently conduct the study, and a third researcher will be consulted in case of disagreement. The psychometric properties will be evaluated according to the COSMIN. This protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO, no. CRD42021244271).
CONCLUSION
This systematic review will attempt to identify and show the available evidence on STS for different groups of PH and report validity, reliability, and responsiveness of different protocols.

Identifiants

pubmed: 36197937
doi: 10.1371/journal.pone.0275646
pii: PONE-D-21-37952
pmc: PMC9534407
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0275646

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Aging Clin Exp Res. 2013 Jun;25(3):305-9
pubmed: 23740582
Qual Life Res. 2010 May;19(4):539-49
pubmed: 20169472
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545968
Med Sci Sports Exerc. 2011 Jul;43(7):1334-59
pubmed: 21694556
Pulm Circ. 2021 Mar 29;11(2):2045894021999955
pubmed: 33854767
BMC Med Res Methodol. 2010 Mar 18;10:22
pubmed: 20298572
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Int J Public Health. 2013 Dec;58(6):949-53
pubmed: 23974352
Epidemiol Serv Saude. 2017 Jul-Sep;26(3):649-659
pubmed: 28977189
Respir Med. 2007 Feb;101(2):286-93
pubmed: 16806873
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Rev Bras Ter Intensiva. 2019;31(1):27-33
pubmed: 30892478
PLoS One. 2021 Feb 12;16(2):e0246781
pubmed: 33577586
BMC Med Res Methodol. 2020 Dec 3;20(1):293
pubmed: 33267819
Cochrane Database Syst Rev. 2014 May 26;(5):CD007232
pubmed: 24859467
Qual Life Res. 2018 May;27(5):1147-1157
pubmed: 29435801
Thorax. 2013 Nov;68(11):1015-20
pubmed: 23783372
Am J Respir Cell Mol Biol. 2014 Jan;50(1):74-86
pubmed: 23972212
COPD. 2020 Dec;17(6):655-661
pubmed: 33023324
J Clin Epidemiol. 2010 Jul;63(7):737-45
pubmed: 20494804
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41
pubmed: 24355639
Respir Care. 2018 Aug;63(8):1040-1049
pubmed: 29789413
Eur Heart J. 2016 Jan 1;37(1):67-119
pubmed: 26320113
Rev Assoc Med Bras (1992). 2006 May-Jun;52(3):139-43
pubmed: 16847518
Respir Med. 2017 Jul;128:70-77
pubmed: 28610673
Curr Cardiol Rev. 2015;11(1):73-9
pubmed: 24251459
Int J Cardiol. 2020 Apr 1;304:159-163
pubmed: 31980271

Auteurs

Natália Lopes Cardoso (NL)

Laboratory of Technological Innovation in Rehabilitation and PneumoCardioVascular Lab/HUOL, Onofre Lopes University Hospital, Brazilian Company of Hospital Services (EBSERH), Federal University of Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.

Joceline Ferezini de Sá (JF)

Laboratory of Cardiorespiratory and Metabolic Assessment-CORE/HUOL, Onofre Lopes University Hospital, Brazilian Company of Hospital Services (EBSERH), Federal University of Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.

Larissa F E do Nascimento (LFE)

Laboratory of Technological Innovation in Rehabilitation and PneumoCardioVascular Lab/HUOL, Onofre Lopes University Hospital, Brazilian Company of Hospital Services (EBSERH), Federal University of Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.

Luciana A Mendes (LA)

Department of Biomedical Engineering, Federal University of Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.

Selma Bruno (S)

Laboratory of Cardiorespiratory and Metabolic Assessment-CORE/HUOL, Onofre Lopes University Hospital, Brazilian Company of Hospital Services (EBSERH), Federal University of Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.

Rodrigo Torres-Castro (R)

Department of Physical Therapy, Faculty of Medicine, University of Chile, Santiago, Chile.

Guilherme A F Fregonezi (GAF)

Laboratory of Technological Innovation in Rehabilitation and PneumoCardioVascular Lab/HUOL, Onofre Lopes University Hospital, Brazilian Company of Hospital Services (EBSERH), Federal University of Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.

Vanessa R Resqueti (VR)

Laboratory of Technological Innovation in Rehabilitation and PneumoCardioVascular Lab/HUOL, Onofre Lopes University Hospital, Brazilian Company of Hospital Services (EBSERH), Federal University of Rio Grande do Norte (UFRN), Natal, Rio Grande do Norte, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH